Researcher Spotlight: Niloufer Khan, MD, MS Memorial Sloan Kettering Cancer Center Cutaneous T-cell lymphoma (CTCL) is a type of skin lymphoma usually managed as a chronic disease without a standard frontline therapy, and treatment plans typically vary from patient to patient.…
Researcher Spotlight: Richa Kapoor, PhD Perelman School of Medicine, University of Pennsylvania T-cell lymphomas are aggressive cancer types that exhibit clinical and genetic heterogeneity, and current therapies do not incorporate personalized medicine opportunities. Research has shown that cutaneous T-cell lymphoma…
Researcher Spotlight: Pamela Allen, MD Emory University/Winship Cancer Institute Patients with advanced-stage cutaneous T-cell lymphoma (CTCL) have a median survival of fewer than five years and often experience debilitating itchy red skin. Patients with CTCL may be treated with extracorporeal…